Acute differentiated dendritic cell leukemia: A variant form of pediatric acute myeloid leukemia with MLL translocation [6]

Leukemia

Volumn 21, Issue 2, 2007, Pages 360-362

  Nigro, L L O ^a   Sainati, L ^b   Leszl, A ^b   Mirabile, E ^a   Spinelli, M ^b   Consarino, C ^c   Di Cataldo, A ^a   Magro, S ^c   Felix, C A ^d   Basso, G ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c PUGLIESE CIACCIO HOSPITAL   (Italy)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 NAPHTHYL ACETATE ESTERASE; CD83 ANTIGEN; CD86 ANTIGEN; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; FLUDARABINE; GLYCOPROTEIN P 15095; GRANULOCYTE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; IDARUBICIN; MIXED LINEAGE LEUKEMIA PROTEIN; MYELOPEROXIDASE;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; BONE MARROW BIOPSY; BONE MARROW CELL; CANCER CLASSIFICATION; CASE REPORT; CELL DIFFERENTIATION; CHILDHOOD CANCER; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOPLASM; DEMOGRAPHY; DENDRITIC CELL; DRUG MEGADOSE; FEMALE; GENE REARRANGEMENT; GENE TRANSLOCATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; INFANT; LETTER; LEUKEMIA CELL; MALE; MORPHOLOGY; MULTIPLE CYCLE TREATMENT; PHAGOCYTOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 33846553616     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404480     Document Type: Letter

References (8)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-252.
2. Hagihara M, Shimakura Y, Tsuchiya T, Ueda Y, Gansuvd B, Munkhbat B et al. The efficient generation of CD83 positive immunocompetent dendritic cells from CD34 positive acute myelomonocytic or monocytic leukemia cells in vitro. Leuk Res 2001; 25: 249-258.
3. Woiciechowsky A, Regn S, Kolb H-J, Roskrow M. Leukemic dendritic cells generated in the presence of FLT3 ligand have the capacity to stimulate an autologous leukemia-specific cytotoxic response from patients with acute myeloid leukemia. Leukemia 2001; 15: 246-255.
4. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Medicine 1985; 103: 620-625.
5. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J et al. The WHO classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee, Airlie House, Virginia, November 1997. Histopathology 2000; 36: 69-86.
6. Maecker B, Mougiakakos D, Zimmermann M, Behrens M, Hollander S, Schrauder A et al. Dendritic cell deficiencies in pediatric acute lymphoblastic leukemia patients. Leukemia 2006; 20: 645-649.
7. Jacob MC, Chaperot L, Mossuz P, Feuillard J, Valensi F, Leroux D et al. CD4+CD56+ lineage negative malignancies: A new entity developed from malignant early plasmacytoid dendritic cells. Haematologica 2003; 88: 941-955.
8. Fujii S-I, Shimizu K, Koji F, Kawano F. Malignant counterpart of myeloid dendritic cell (DC) belonging to acute myelogenous leukemia (AML) exhibits a dichotomous immunoregulatory potential. J Leuk Biol 2003; 73: 82-90.